Funded Project Details - FY2021
|Title:|| Ketamine for Treatment Resistant Late-Life Depression|
Sanjay J. Mathew
|Congressional District Code:
||Clinical Science R&D
|| October 2015 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Project Summary/Abstract: More than eleven million (45.7%) U.S. Veterans are at least 65 years of age with up to 20% suffering from depression. Late-life depression is a common disorder which is often under-diagnosed and under-treated and has been associated with increased functional impairment regardless of symptom severity. Real-world effectiveness of antidepressants is sub-optimal or incomplete in up to two-thirds of patients with treatment resistant depression (Trivedi, 2006; Rush, 2006). F...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.